What caused the ORCHIDPHAR.BO stock volume spike on 16 Jan 2026?

The spike to **24,701** shares likely reflects concentrated orders or a block trade. With price down **-2.53%** but heavy volume, it signals matched seller and buyer interest rather than broad retail panic. Look for related corporate or sector announcements to confirm the cause.

How should traders use the ORCHIDPHAR.BO stock signal?

Treat the volume spike as a liquidity signal. If price rises on continued high volume, it confirms buying interest. If volume fades and price breaks **INR 733.00**, it may be distribution. Use stop-losses and watch intraday follow-through before initiating larger positions.

What are the key valuation metrics for ORCHIDPHAR.BO stock to watch?

Monitor **PE 65.35**, **PB 4.88**, EV/EBITDA **4.42**, debt-to-equity **0.64**, and current ratio **1.35**. These show modest profitability and moderate leverage; any re-rating needs clearer cash flow improvement.

Does Meyka AI provide a price forecast for ORCHIDPHAR.BO stock?

Yes. Meyka AI's forecast model projects a 12-month target of **INR 950.00**, implying **~28.13%** upside from **INR 741.55**. Forecasts are model-based projections and not guarantees; use them with fundamental checks.

IN Stocks

66x volume spike in ORCHIDPHAR.BO (Orchid Pharma BSE) 16 Jan 2026: watch liquidity

ByDanny Kontos January 16, 2026January 16, 2026

We saw a sharp volume surge in ORCHIDPHAR.BO stock on 16 Jan 2026, with 24,701 shares traded versus an average of 372, a 66.40x jump. The price closed at INR 741.55, down -2.53% from the previous close of INR 760.80. This volume spike on the BSE (India) flags higher liquidity and possible institutional activity. We examine what the trade flow, valuation and sector context mean for short-term trading and a medium-term outlook.